Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | 12-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 860 | 2,020 | 250 | 880 | 1,480 |
| Receivables | 80 | 3 | 30 | 10 | 0 |
| Other current assets | 130 | 37 | 130 | 50 | 60 |
| TOTAL | $1,070 | $2,060 | $410 | $940 | $1,540 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1,010 | 1,000 | 1,000 | N/A |
| Investments And Advances | 150 | 150 | 150 | 150 | 150 |
| Other Non-Current Assets | 3,268 | 3,018 | 408 | 418 | 428 |
| TOTAL | $3,418 | $4,178 | $1,558 | $1,568 | $578 |
| Total Assets | $4,600 | $5,360 | $1,130 | $1,700 | $2,350 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 720 | 720 | 550 | 450 | 390 |
| Accrued Expenses | 70 | 4 | 9 | 10 | 30 |
| Other current liabilities | 150 | 150 | 80 | 80 | 0 |
| TOTAL | $980 | $930 | $720 | $650 | $530 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $3 | $8 | $20 |
| Total Liabilities | $980 | $930 | $730 | $660 | $550 |
| Shareholders' Equity | |||||
| Common Shares | 60 | 60 | 30 | 30 | 30 |
| Retained earnings | -26,450 | -25,540 | -24,830 | -23,940 | -23,140 |
| Other shareholders' equity | 0 | -10 | 0 | 0 | 0 |
| TOTAL | $3,610 | $4,430 | $400 | $1,040 | $1,790 |
| Total Liabilities And Equity | $4,590 | $5,360 | $1,130 | $1,700 | $2,340 |